دورية أكاديمية
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
العنوان: | Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
---|---|
المؤلفون: | Grimm, Sabine E.Aff1, Fayter, Debra, Ramaekers, Bram L. T., Petersohn, Svenja, Riemsma, Rob, Armstrong, Nigel, Pouwels, Xavier, Witlox, Willem, Noake, Caro, Worthy, Gillian, Kleijnen, Jos, Joore, Manuela A. |
المصدر: | PharmacoEconomics. 37(10):1195-1207 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 11707690 11792027 |
---|---|
DOI: | 10.1007/s40273-019-00792-7 |